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Hypothesis
▪ Patients admitted to the trauma service on
warfarin anticoagulation have inappropriate
indications for anticoagulation

Background
• Clinical practice guidelines for
anticoagulation are outlined in Chest 2012
• Fall risk currently does not factor into
guidelines for anticoagulation with warfarin
• Prior studies have demonstrated inferior
outcomes in trauma patients on
anticoagulation

Methods
• Retrospective chart review of all patients admitted

•
•

to the trauma service on preexisting warfarin
anticoagulation at a level 1 trauma center between
January 1, 2012 and December 31, 2012
Indications for anticoagulation determined, along
with whether the indications meet published
guidelines
Other data points collected included admitting
international normalized ratio, mechanism, length
of stay, injury severity score, and inpatient mortality

Results
▪ 2,744 admissions during the study period
▪ Study group consisted of 219 patients on
warfarin anticoagulation
▪ Median age 77 years
▪ Most common traumatic mechanisms were
mechanical fall (84%), MVC (10%)
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Recommendations for Anticoagulation
for DVT
▪ For patients with a proximal DVT provoked
by surgery or a non-surgical transient
cause, anticoagulation should be
continued for 3 months
▪ For patients with an unprovoked DVT,
continue anticoagulation for 3 months,
followed by evaluation of risk-benefit ratio
of extended therapy

Meeting Guidelines
▪ Guidelines for each indication were

▪

▪

individually examined
Indications clearly fell within the Chest 2012
guidelines in 84% and did not in 4% of
patients; for the remaining 12% of patients
the documentation was insufficient to clearly
define whether guidelines were met
Specifically for the population of patients with
afib, 99% met guidelines
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Inpatient Mortality Rates
Overall Group
▪ All trauma admissions
in study period (2,744
patients) – 2.9%
▪ 1,056 patients over
age 65 – 4.5%
▪ Study group of 219
patients on coumadin
anticoagulation – 6.8%

Inpatient Mortality by
admission INR
• Subtherapeutic 4.4%
• Therapeutic 7.8 %
• Supratherapeutic 8.5%

Conclusion
• Contrary to the study’s hypothesis, the
majority of the study group fell within Chest
guidelines for anticoagulation
• Our data supports earlier studies
suggesting inferior outcomes for patients
on anticoagulation

Areas for Further Study
▪ Should fall risk factor into anticoagulation
schema?
▪ How will the use of newer oral direct
thrombin inhibitor agents affect outcomes
in trauma?
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